Copland, Emma

Coupland, Carol A. C.

Handunnetthi, Lahiru

Harnden, Anthony

Hippisley-Cox, Julia

Hirst, Jennifer

Hunt, David P. J.

Mills, Nicholas L.

Moss, Paul

Patone, Martina

Robertson, Chris

Saatci, Defne

Sheikh, Aziz

English

University of Birmingham Research Portal

  University of BirminghamAuthor Correction: Safety outcomes followingCOVID-19 vaccination and infection in 5.1 millionchildren in EnglandCopland, Emma; Patone, Martina; Saatci, Defne; Handunnetthi, Lahiru; Hirst, Jennifer; Hunt,David P. J.; Mills, Nicholas L.; Moss, Paul; Sheikh, Aziz; Coupland, Carol A. C.; Harnden,Anthony; Robertson, Chris; Hippisley-Cox, JuliaDOI:10.1038/s41467-024-50151-0License:Creative Commons: Attribution (CC BY)Document VersionPublisher's PDF, also known as Version of recordCitation for published version (Harvard):Copland, E, Patone, M, Saatci, D, Handunnetthi, L, Hirst, J, Hunt, DPJ, Mills, NL, Moss, P, Sheikh, A, Coupland,CAC, Harnden, A, Robertson, C & Hippisley-Cox, J 2024, 'Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England', Nature Communications, vol. 15, no. 1, 5723.https://doi.org/10.1038/s41467-024-50151-0Link to publication on Research at Birmingham portalGeneral rightsUnless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or thecopyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposespermitted by law.•Users may freely distribute the URL that is used to identify this publication.•Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of privatestudy or non-commercial research.•User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)•Users may not further distribute the material nor use it for the purposes of commercial gain.Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.When citing, please reference the published version.Take down policyWhile the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has beenuploaded in error or has been deemed to be commercially or otherwise sensitive.If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access tothe work immediately and investigate.Download date: 04. Aug. 2024Corrections&amendmentsAuthor Correction: Safety outcomes following COVID-19vaccination and infection in 5.1 million children in EnglandEmma Copland , Martina Patone, Defne Saatci , Lahiru Handunnetthi,Jennifer Hirst, David P. J. Hunt , Nicholas L. Mills , Paul Moss , Aziz Sheikh ,Carol A. C. Coupland, Anthony Harnden, Chris Robertson &Julia Hippisley-CoxThe original version of this article contained information on vaccine dose amount (full or half)inTable 2 andSupplementary Table 1. Thishas subsequently been found tobe inaccurate due toinconsistent coding in the rawdata.The vaccinedoseamount has thereforebeen removed fromTable 2 and Supplementary Table 1. This data was not used elsewhere in the analysis. Anadditional line has been added to the introduction to summarise vaccine doses that were givento the population:“Those aged 12 years and above were given a full dose of BNT162b2 vaccine (30 micro-grams), and children aged 5–11 yearsweregiven a doseof 10microgramsof BNT162b2 vaccine.”These changes have been made in the PDF and HTML versions of the article.Additional informationSupplementary information The online version contains supplementary material available athttps://doi.org/10.1038/s41467-024-50151-0.Open Access This article is licensed under a Creative Commons Attribution 4.0 InternationalLicense, which permits use, sharing, adaptation, distribution and reproduction in any medium orformat, as long as you give appropriate credit to the original author(s) and the source, provide alink to the Creative Commons licence, and indicate if changes were made. The images or otherthird party material in this article are included in the article’s Creative Commons licence, unlessindicated otherwise in a credit line to the material. If material is not included in the article’sCreative Commons licence and your intended use is not permitted by statutory regulation orexceeds the permitted use, youwill need to obtain permission directly from the copyright holder.To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.© The Author(s) 2024Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-47745-z,published online 27 May 2024https://doi.org/10.1038/s41467-024-50151-0Check for updatesnature communications         (2024) 15:5723 | 11234567890():,;1234567890():,;

Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England

Copland, E

Patone, M

Saatci, D

Handunnetthi, L

Hirst, J

Hunt, DPJ

Mills, NL

Moss, P

Sheikh, A

Coupland, CAC

Harnden, A

Robertson, C

Hippisley-Cox, J

Queen Mary Research Online

Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England.

  University of BirminghamAuthor Correction: Safety outcomes followingCOVID-19 vaccination and infection in 5.1 millionchildren in EnglandCopland, Emma; Patone, Martina; Saatci, Defne; Handunnetthi, Lahiru; Hirst, Jennifer; Hunt,David P. J.; Mills, Nicholas L.; Moss, Paul; Sheikh, Aziz; Coupland, Carol A. C.; Harnden,Anthony; Robertson, Chris; Hippisley-Cox, JuliaDOI:10.1038/s41467-024-50151-0License:Creative Commons: Attribution (CC BY)Document VersionPublisher's PDF, also known as Version of recordCitation for published version (Harvard):Copland, E, Patone, M, Saatci, D, Handunnetthi, L, Hirst, J, Hunt, DPJ, Mills, NL, Moss, P, Sheikh, A, Coupland,CAC, Harnden, A, Robertson, C & Hippisley-Cox, J 2024, 'Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England', Nature Communications, vol. 15, no. 1, 5723.https://doi.org/10.1038/s41467-024-50151-0Link to publication on Research at Birmingham portalGeneral rightsUnless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or thecopyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposespermitted by law.•Users may freely distribute the URL that is used to identify this publication.•Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of privatestudy or non-commercial research.•User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)•Users may not further distribute the material nor use it for the purposes of commercial gain.Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.When citing, please reference the published version.Take down policyWhile the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has beenuploaded in error or has been deemed to be commercially or otherwise sensitive.If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access tothe work immediately and investigate.Download date: 12. Sep. 2024Corrections&amendmentsAuthor Correction: Safety outcomes following COVID-19vaccination and infection in 5.1 million children in EnglandEmma Copland , Martina Patone, Defne Saatci , Lahiru Handunnetthi,Jennifer Hirst, David P. J. Hunt , Nicholas L. Mills , Paul Moss , Aziz Sheikh ,Carol A. C. Coupland, Anthony Harnden, Chris Robertson &Julia Hippisley-CoxThe original version of this article contained information on vaccine dose amount (full or half)inTable 2 andSupplementary Table 1. Thishas subsequently been found tobe inaccurate due toinconsistent coding in the rawdata.The vaccinedoseamount has thereforebeen removed fromTable 2 and Supplementary Table 1. This data was not used elsewhere in the analysis. Anadditional line has been added to the introduction to summarise vaccine doses that were givento the population:“Those aged 12 years and above were given a full dose of BNT162b2 vaccine (30 micro-grams), and children aged 5–11 yearsweregiven a doseof 10microgramsof BNT162b2 vaccine.”These changes have been made in the PDF and HTML versions of the article.Additional informationSupplementary information The online version contains supplementary material available athttps://doi.org/10.1038/s41467-024-50151-0.Open Access This article is licensed under a Creative Commons Attribution 4.0 InternationalLicense, which permits use, sharing, adaptation, distribution and reproduction in any medium orformat, as long as you give appropriate credit to the original author(s) and the source, provide alink to the Creative Commons licence, and indicate if changes were made. The images or otherthird party material in this article are included in the article’s Creative Commons licence, unlessindicated otherwise in a credit line to the material. If material is not included in the article’sCreative Commons licence and your intended use is not permitted by statutory regulation orexceeds the permitted use, youwill need to obtain permission directly from the copyright holder.To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.© The Author(s) 2024Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-47745-z,published online 27 May 2024https://doi.org/10.1038/s41467-024-50151-0Check for updatesnature communications         (2024) 15:5723 | 11234567890():,;1234567890():,;

https://pure-oai.bham.ac.uk/ws/files/231901426/41467_2024_Article_50151.pdf

Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England

Abstract

Similar works

Full text

Available Versions

University of Birmingham Research Portal

Queen Mary Research Online

University of Birmingham Research Portal